Davis Polk advised BRP Group, Inc. on its $258.1 million follow-on offering of 8,750,000 shares of Class A common stock. The shares of Class A common stock are listed on the Nasdaq Global…
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Esperion Therapeutics, Inc. of $250 million aggregate principal amount of…